How certain proteins respond to mechanical forces in cells
Instrument Supplement: Mechanisms of Mechanotransduction by LIM Domain Proteins
This study is looking at how certain proteins in our cells sense and react to physical forces, which is important for understanding diseases like heart problems and cancer, and it hopes to find new ways to help treat these conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11001329 on NIH RePORTER |
What this research studies
This research investigates how LIM domain proteins detect and respond to mechanical forces within cells, which is crucial for understanding various diseases like atherosclerosis and cancer. By using advanced techniques such as live cell imaging and mathematical modeling, the study aims to uncover the mechanisms of mechanotransduction, the process by which cells convert mechanical stimuli into biochemical signals. This could lead to new insights into how cellular behavior is influenced by physical changes in their environment, ultimately aiding in the development of treatments for related diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions related to atherosclerosis, heart failure, or cancer.
Not a fit: Patients with conditions unrelated to cellular mechanotransduction or those not affected by mechanical forces in their disease processes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for diseases influenced by mechanical forces, such as heart disease and cancer.
How similar studies have performed: Previous research has shown promise in understanding mechanotransduction pathways, indicating that this approach could yield valuable insights.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Gardel, Margaret Lise — University of Chicago
- Study coordinator: Gardel, Margaret Lise
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.